Background
MRI has been suggested as a radiation‐free imaging modality to investigate early structural alterations and regional functional impairment in cystic fibrosis (CF) lung disease.
Purpose/Hypothesis
To compare functional and morphological MRI changes over the course of the disease to changes in spirometry.
Study Type
Longitudinal retrospective study.
Population
Twenty patients with CF lung disease (at baseline, age = 16.5 (13.3–20.6) years, forced expiratory volume in 1 second (as % of predicted [%pred]) FEV1 = 71 (59–87) %pred, forced expiratory flow at 25–75% of forced vital capacity FEF25‐75 = 39 (25–63) %pred.
Field Strength/Sequence
1.5T / T2‐weighted HASTE; T2‐weighted TSE‐PROPELLER; T2‐weighted bSSFP; T1‐weighted 3D GRE.
Assessment
Nonenhanced chest MRI and spirometry were retrospectively collected over a 3‐year period from the initial recruitment visit. Images acquired at end‐inspiration and end‐expiration were registered by software using the optical flow method to measure expiratory‐inspiratory differences in MR signal‐intensity (Δ1H‐MRI). Measures of CF functional impairment were defined from Δ1H‐MRI: Δ1H‐MRI median, Δ1H‐MRI quartile coefficient of variation (QCV), and percent low‐signal‐variation volume (LVV). MR images were also evaluated by three readers using a CF‐specific scoring system.
Statistical Tests
Spearman correlation analysis, Spearman rank correlation analysis, linear mixed‐effect model analysis, intraclass correlation coefficient.
Results
Functional imaging parameters and total morphological score correlated with all spirometric measures, as did subscores of bronchial wall thickening/bronchiectasis, mucus plugging, and consolidation. Overall, the percent change of Δ1H‐MRI median correlated with the percent change of FEV1 (ΔFEV1, r = 0.41, P < 0.01) and the percent change of FEF25‐75 (ΔFEF25‐75%, r = 0.38, P < 0.01). The percent change of LVV correlated with ΔFEV1 (r = –0.47, P < 0.001) and ΔFEF25‐75 (r = –0.50, P < 0.001).
Data Conclusion
These preliminary results suggest that nonenhanced multivolume MRI may provide a feasible tool to regionally map early pulmonary alterations for longitudinal evaluation of CF lung disease, without exposing the patients to ionizing radiation.
Level of Evidence
3T
Technical Efficacy Stage
5